Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (74) clinical trials

Northern California Research is enrolling participants for a Mild Dementia/Alzheimer's Disease study. The purpose of this study is to see if daily doses of a study medication will improve the symptoms of mild dementia due to Alzheimer's disease. This study medication has been designed to change the cortisol levels in ...

Phase

Study Description: The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and progression of clinical symptoms associated with Alzheimer's disease (AD) in participants at the risk to develop clinical symptoms based on their age and genotype. ...

Phase

The primary objective is to evaluate the effects of administration of neflamapimod (VX-745) for 24-weeks on immediate and delayed recall aspects of episodic memory, as assessed by the Hopkins Verbal Learning Test – Revised (HVLT-R) in subjects with mild Alzheimer’s disease (AD).

Phase

Over 5 million Americans are living with Alzheimer’s. That means millions of families are learning how to cope with this disease. If you or a loved one has been diagnosed with mild to moderate Alzheimer’s, you may be interested in this research study. Clinical Research Associates in Nashville, TN is ...

Phase

Patient Inclusion Criteria: Ages: over 60 Male/Female 18 week long Clinical Trial Patient may not be full time permanent resident of nursing home Clinical diagnosis of probable AD with supportive brain imaging documentation Have existing neuropsychiatric symptoms as defined by a score equal or greater than 10 on the NPI ...

Phase

Patient Inclusion Criteria: Ages: over 50-90 Male/Female 90 week Long Clinical Trial MMSE score 22-30 Positive amyloid load as indicated by PET assessment Age between 50 and 90 years, inclusive MMSE score equal to or greater than 22, and equal to or less than 30, at Screening and Baseline BMI ...

Phase

Patient Inclusion Criteria: Ages: over 50-90 Male/Female 12 Month Long Clinical Trial MMSE score 14-20 Adult patients, 50-90 years of age inclusive at time of screening Probable Alzheimer disease, based on the National Institute of Neurological and Communicative Disorders and Stroke (NINCDS)/Alzheimer's Disease and Related Disorders Association (ADRDA) and DSM-IV-TR ...

Phase

Alzheimer's disease is the most common neurodegenerative disorder and its prevalence steeply increases. The small number of effective treatments for Alzheimer's disease highlights a need for further research into novel therapeutic possibilities. Glutamate-mediated excitotoxicity in neuropsychiatric disorders and in particular in Alzheimer's disease has been shown to cause significant cerebral ...

Phase

This is a multicenter, multinational study that be conducted to test the safety and effectiveness of an investigational medication against placebo ( a substance that looks like the study drug but does not contain the active ingredient) in patients with memory loss due to mild cognitive impairment or mild Alzheimer's ...

Phase

Are you or someone you care for experiencing memory loss possibly due to Alzheimer's disease?

Phase